Skin Care Carries J&J Consumer Biz. In Quarter Marred By OTC Drug Recall
This article was originally published in The Rose Sheet
Executive SummaryJohnson & Johnson's skin-care franchise helped offset weak oral-care sales and hampered over-the-counter and nutritionals business associated with a recall of Motrin, Tylenol and other products in the firm's fiscal 2010 first quarter
You may also be interested in...
Though the firm claims to have come a long way in improving management of OTC pharma quality control since its 2009/2010 recalls, a May 22 warning letter regarding post-market monitoring and pre-market notifications for K-Y moisturizers suggests consumer devices are not getting the same level of attention.